Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.
about
Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein geneMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsUse of Reporter Genes in the Generation of Vaccinia Virus-Derived VectorsThe evolution of poxvirus vaccinesMonoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophagesRecombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challengeExpression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVAViral vector-based influenza vaccines.UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).Induction of microthrombotic thrombocytopenia in normal mice by transferring a platelet-reactive, monoclonal anti-gp70 autoantibody established from MRL/lpr mice: an autoimmune model of thrombotic thrombocytopenic purpura.Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytesEstablishment of monoclonal anti-retroviral gp70 autoantibodies from MRL/lpr lupus mice and induction of glomerular gp70 deposition and pathology by transfer into non-autoimmune mice.Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin.Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein geneJC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectorsImmune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein.Virus-vectored influenza virus vaccines.Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicityVaccinia virus vectors: new strategies for producing recombinant vaccines.Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.Spinning molecular immunology into successful immunotherapy.A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus.Next generation: tuberculosis vaccines that elicit protective CD8+ T cellsNYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors.Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoproteinInnate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta.Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein.Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenzaIdentification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.Enteric immunization of mice against influenza with recombinant vacciniaRespiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit.Towards a hepatitis A vaccine. A review.Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clonesIdentification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes.On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.
P2860
Q24606451-357E6558-9567-4B90-9151-995B83D598E8Q24648051-BF5D4BF8-7B71-4861-843D-E9490D8F3963Q26746915-AB928352-46E2-4084-91B9-60B47B09CEB5Q26995905-7AA19E13-CEBF-44BE-8DF5-24AEFC0F1101Q27486215-0BBA4EF0-9EC8-4FDA-818B-BA5147D06CD1Q27486835-08749C5A-28F8-407A-A028-D2C272A52304Q28727937-0BE574FF-DB12-4A30-B277-0A8B8B216B2FQ30390938-4E0807EE-AAC2-4632-808B-FA785CF94804Q30414377-52F1D0D7-F2C7-487E-9CB2-87C73B4D2E8EQ33320536-9A8E059E-C925-4BA3-B91C-2053F53BF58DQ33331009-02068767-6C8E-4961-AC41-FDAF443ADE5FQ33612515-90975F07-5E05-42BB-9A8C-7F0D6313CB9DQ33803417-FFF150E9-C9F0-4048-89EE-DF7FE7C6AD2DQ33829395-E2134E13-A622-47DF-AE34-6BEA6E0FED61Q33829701-C96C2F95-9FB2-46F5-82F5-9A1DB2ED19B5Q33838943-E2C34A0F-FE9E-4768-869F-CE6392E2FDCDQ33879343-E0221555-B2F1-402D-B608-DD1BC8587F52Q34080569-F9FF2164-623F-4B01-8E85-99E30ECAB7F5Q34102268-18A480BC-5184-41EE-B6DB-9D50491283D1Q34162769-E7300F53-A388-4C66-BC4E-32A07A7C128BQ34186587-4F9912B2-DAED-4CDF-BAFB-85AFE794B95BQ34211635-708A4F96-BE7B-4168-A213-E7587C55EB0FQ34340404-B42143E2-B2E9-4EA9-A015-FD7F8E5CB288Q34632056-AD1F142F-9037-4039-8039-EE3159F60001Q35008790-8CD625EF-FE56-4A18-8542-F7C8987C1980Q35099708-C2D30064-8422-4C07-B8F4-CD01C98B1C06Q35519418-3CB10E44-733D-465C-B37E-7354EE8C2A91Q35585367-26D4BC80-4300-41D5-8BA0-95EEEBA876CFQ35596022-121CAF63-2912-47B1-BD64-EBBC62004563Q35615827-D33A9622-00FF-4146-B435-9D301763F76BQ35865836-2F08D946-D938-4603-96DE-957A172625B1Q35868774-4B9E58D3-8D37-4544-A962-0F883DA44212Q35872183-BF5FA0F4-5BF5-4314-A744-69F8DA516AB2Q35900617-3A55B89F-38B5-472E-AA05-FE5DED70FB5CQ36137180-D3C80BDE-C3B1-4BCB-8EF7-3749D6383B3CQ36250007-7CB67C8D-EB05-437B-B998-A55996281580Q36343961-8196B18F-2565-4B1F-9DF3-29AABE54072DQ36351700-305E0FF8-388E-4671-A3A5-67AAF2BE58AFQ36353327-CA2F4743-4304-4503-8CFB-F722A09B8EFFQ36353887-7E980B77-3068-4992-80F5-5849511274A2
P2860
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Construction and characterizat ...... a virus infection in hamsters.
@en
Construction and characterizat ...... a virus infection in hamsters.
@nl
type
label
Construction and characterizat ...... a virus infection in hamsters.
@en
Construction and characterizat ...... a virus infection in hamsters.
@nl
prefLabel
Construction and characterizat ...... a virus infection in hamsters.
@en
Construction and characterizat ...... a virus infection in hamsters.
@nl
P2093
P2860
P356
P1476
Construction and characterizat ...... a virus infection in hamsters.
@en
P2093
P2860
P304
P356
10.1073/PNAS.80.23.7155
P407
P577
1983-12-01T00:00:00Z